These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

68 related items for PubMed ID: 8768338

  • 1. Risperidone for negative symptoms.
    Zuddas A, Pintor M, Cianchetti C.
    J Am Acad Child Adolesc Psychiatry; 1996 Jul; 35(7):838-9. PubMed ID: 8768338
    [No Abstract] [Full Text] [Related]

  • 2. [Remission of schizophrenic psychosis with negative symptoms with risperidone].
    Lübbe R.
    Fortschr Med; 1996 Feb 28; 114(6):35-6. PubMed ID: 8900527
    [Abstract] [Full Text] [Related]

  • 3. Case study: risperidone in children and adolescents with schizophrenia.
    Quintana H, Keshavan M.
    J Am Acad Child Adolesc Psychiatry; 1995 Oct 28; 34(10):1292-6. PubMed ID: 7592266
    [Abstract] [Full Text] [Related]

  • 4. [Comparative effectiveness of flupenthixol and risperidone on negative symptoms of schizophrenia].
    Philipp M, Lesch OM, Schmauss M, Dose M, Glaser T.
    Psychiatr Prax; 2003 May 28; 30 Suppl 2():S94-6. PubMed ID: 14509050
    [Abstract] [Full Text] [Related]

  • 5. Pathophysiology and treatment of negative symptoms.
    Villeneuve A.
    Can J Psychiatry; 1994 Nov 28; 39(9 Suppl 2):S53-8. PubMed ID: 7533052
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The diagnosis and treatment of children and adolescents with schizophrenia. "My mind is playing tricks on me".
    Kumra S.
    Child Adolesc Psychiatr Clin N Am; 2000 Jan 28; 9(1):183-99, x. PubMed ID: 10674196
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Efficacy of selegiline add on therapy to risperidone in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study.
    Amiri A, Noorbala AA, Nejatisafa AA, Ghoreishi A, Derakhshan MK, Khodaie-Ardakani MR, Hajiazim M, Raznahan M, Akhondzadeh S.
    Hum Psychopharmacol; 2008 Mar 28; 23(2):79-86. PubMed ID: 17972359
    [Abstract] [Full Text] [Related]

  • 12. [Atypical neuroleptics in the child and adolescent].
    Naja WJ, Reneric JP, Bouvard MP.
    Encephale; 1998 Mar 28; 24(4):378-85. PubMed ID: 9809243
    [Abstract] [Full Text] [Related]

  • 13. Risperidone in the treatment of psychotic depression.
    Goto M, Yoshimura R, Kakihara S, Shinkai K, Yamada Y, Kaji K, Ueda N, Nakamura J.
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jun 28; 30(4):701-7. PubMed ID: 16580110
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Enuresis with combined risperidone and SSRI use.
    Took KJ, Buck BJ.
    J Am Acad Child Adolesc Psychiatry; 1996 Jul 28; 35(7):840-1. PubMed ID: 8768340
    [No Abstract] [Full Text] [Related]

  • 16. Efficacy and tolerability of ziprasidone versus risperidone as augmentation in patients partially responsive to clozapine: a randomised controlled clinical trial.
    Zink M, Kuwilsky A, Krumm B, Dressing H.
    J Psychopharmacol; 2009 May 28; 23(3):305-14. PubMed ID: 18562423
    [Abstract] [Full Text] [Related]

  • 17. Risperidone in children with schizophrenia -letter-.
    Lykes WC, Cueva JE.
    J Am Acad Child Adolesc Psychiatry; 1996 Apr 28; 35(4):405-6. PubMed ID: 8919701
    [No Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of long-acting risperidone in elderly patients with schizophrenia and schizoaffective disorder.
    Lasser RA, Bossie CA, Zhu Y, Gharabawi G, Eerdekens M, Davidson M.
    Int J Geriatr Psychiatry; 2004 Sep 28; 19(9):898-905. PubMed ID: 15352149
    [Abstract] [Full Text] [Related]

  • 19. The treatment of negative symptoms: pharmacological and methodological issues.
    Carpenter WT.
    Br J Psychiatry Suppl; 1996 May 28; (29):17-22. PubMed ID: 8733819
    [No Abstract] [Full Text] [Related]

  • 20. Effect of ritanserin, a 5HT2A/2C antagonist, on negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study.
    Akhondzadeh S, Malek-Hosseini M, Ghoreishi A, Raznahan M, Rezazadeh SA.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec 12; 32(8):1879-83. PubMed ID: 18801405
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.